These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 11842925

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Artificial saliva products and drugs to treat xerostomia.
    Wynn RL, Meiller TF.
    Gen Dent; 2000; 48(6):630-6. PubMed ID: 12004654
    [No Abstract] [Full Text] [Related]

  • 23. Preventing radiation induced xerostomia.
    Koukourakis MI, Danielidis V.
    Cancer Treat Rev; 2005 Nov; 31(7):546-54. PubMed ID: 16257125
    [Abstract] [Full Text] [Related]

  • 24. Sensitivity of salivary glands to radiation: from animal models to therapies.
    Grundmann O, Mitchell GC, Limesand KH.
    J Dent Res; 2009 Oct; 88(10):894-903. PubMed ID: 19783796
    [Abstract] [Full Text] [Related]

  • 25. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
    Valdez IH, Wolff A, Atkinson JC, Macynski AA, Fox PC.
    Cancer; 1993 Mar 01; 71(5):1848-51. PubMed ID: 8448748
    [Abstract] [Full Text] [Related]

  • 26. [Future therapy strategies for salivary gland impairment].
    Aframian DJ, Palmon A, Nahlieli O.
    Refuat Hapeh Vehashinayim (1993); 2004 Jul 01; 21(3):43-50, 93. PubMed ID: 15503981
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Acquired salivary dysfunction. Drugs and radiation.
    Fox PC.
    Ann N Y Acad Sci; 1998 Apr 15; 842():132-7. PubMed ID: 9599303
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Assessment of radiation injuries to the salivary glands after treatment of head and neck cancers].
    Urban A, Miszczyk L, Maciejewski B.
    Otolaryngol Pol; 2005 Apr 15; 59(1):21-5. PubMed ID: 15915914
    [Abstract] [Full Text] [Related]

  • 31. Chronic Phenotypes Underlying Radiation-Induced Salivary Gland Dysfunction.
    Gunning JA, Limesand KH.
    J Dent Res; 2024 Jul 15; 103(8):778-786. PubMed ID: 38808518
    [Abstract] [Full Text] [Related]

  • 32. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z, Németh A, Bán A, Mukics A, Nyárády J, Ember I, Olasz L.
    Anticancer Res; 2006 Jul 15; 26(2B):1557-62. PubMed ID: 16619571
    [Abstract] [Full Text] [Related]

  • 33. Xerostomia: diagnosis and management.
    Greenspan D.
    Oncology (Williston Park); 1996 Mar 15; 10(3 Suppl):7-11. PubMed ID: 8723427
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dramatic and prolonged decrease of whole salivary secretion in nasopharyngeal carcinoma patients treated with radiotherapy.
    Jen YM, Lin YC, Wang YB, Wu DM.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar 15; 101(3):322-7. PubMed ID: 16504865
    [Abstract] [Full Text] [Related]

  • 37. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
    Jham BC, Teixeira IV, Aboud CG, Carvalho AL, Coelho Mde M, Freire AR.
    Oral Oncol; 2007 Feb 15; 43(2):137-42. PubMed ID: 16798061
    [Abstract] [Full Text] [Related]

  • 38. Radiation-induced xerostomia in patients with head and neck cancer: a literature review.
    Dirix P, Nuyts S, Van den Bogaert W.
    Cancer; 2006 Dec 01; 107(11):2525-34. PubMed ID: 17078052
    [Abstract] [Full Text] [Related]

  • 39. [Theses 25 years after date 23. Developments in the prevention and treatment of xerostomia].
    Vissink A.
    Ned Tijdschr Tandheelkd; 2010 Sep 01; 117(9):453-9. PubMed ID: 20968105
    [Abstract] [Full Text] [Related]

  • 40. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C, LeVeque F, Swann RS, White R, Schulsinger A, Hodson DI, Meredith R, Foote R, Brachman D, Lee N.
    J Support Oncol; 2006 May 01; 4(5):252-8. PubMed ID: 16724649
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.